How many institutions held TXMD - TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share in Q2 2022?

36 institutional investors reported TXMD - TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share for Q2 2022. Use the holders table for investor-level position and value details.

TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD)

Q: What does CUSIP 88338N206 represent in this 13F holders report?

CUSIP 88338N206 is the security identifier for TXMD - TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 88338N206

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 11,676,558
Total 13F shares: 1,993,507
Share change: +1,982,707
Total reported value: $19,835,726
Put/Call ratio: 188%
Price per share: $9.95
Number of holders: 36
Value change: +$19,831,622
Number of buys: 36
Number of sells: 2

Quarterly Holders Quick Answers

What is CUSIP 88338N206?
CUSIP 88338N206 identifies TXMD - TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 88338N206:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of TXMD - TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
John C.k. Milligan IV	3/4/5	Secretary/CEO of subsidiary	— mixed-class rows	5,542,076 mixed-class rows	$12,698,322	—	10 May 2021	3/4/5
Hugh O'Dowd	3/4/5	Chief Executive Officer	— mixed-class rows	4,250,000 mixed-class rows	$11,415,713	—	31 Mar 2022	3/4/5
BlackRock Finance, Inc.	13F	Company	— class O/S missing	24,442,512	$9,286,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	— class O/S missing	17,448,224	$6,631,000	—	31 Mar 2022	13F
Robert G. Finizio	3/4/5	CEO, Director	— mixed-class rows	2,240,000 mixed-class rows	$5,305,888	—	01 Jul 2021	3/4/5
STATE STREET CORP	13F	Company	— class O/S missing	7,259,095	$2,758,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	— class O/S missing	7,256,718	$2,757,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	— class O/S missing	6,628,058	$2,518,000	—	31 Mar 2022	13F
C WorldWide Group Holding A/S	13F	Company	— class O/S missing	6,189,834	$2,352,000	—	31 Mar 2022	13F
Rubric Capital Management LP	13F	Company	— class O/S missing	5,344,302	$2,031,000	—	31 Mar 2022	13F
James Darecca	3/4/5	Chief Financial Officer	— mixed-class rows	558,163 mixed-class rows	$1,857,402	—	10 Aug 2021	3/4/5
OSAIC HOLDINGS, INC.	13F	Company	— class O/S missing	24,924	$1,762,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	— class O/S missing	3,536,676	$1,344,000	—	31 Mar 2022	13F
Edward Borkowski	3/4/5	EVP, Operations	— mixed-class rows	560,000 mixed-class rows	$1,326,472	—	01 Jul 2021	3/4/5
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	13F	Company	— class O/S missing	3,445,600	$1,309,000	—	31 Mar 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	— class O/S missing	3,147,599	$1,196,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	— class O/S missing	2,860,361	$1,087,000	—	31 Mar 2022	13F
STIFEL FINANCIAL CORP	13F	Company	— class O/S missing	2,833,967	$1,077,000	—	31 Mar 2022	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	— class O/S missing	1,619,080	$615,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	— class O/S missing	1,061,697	$419,000	—	31 Mar 2022	13F
MACKENZIE FINANCIAL CORP	13F	Company	— class O/S missing	21,206	$403,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	— class O/S missing	1,049,708	$399,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	— class O/S missing	858,241	$327,000	—	31 Mar 2022	13F
FMR LLC	13F	Company	— class O/S missing	808,461	$308,000	—	31 Mar 2022	13F
ROYAL BANK OF CANADA	13F	Company	— class O/S missing	787,646	$299,000	—	31 Mar 2022	13F
Asset Management Group, Inc.	13F	Company	— class O/S missing	735,040	$279,000	—	31 Mar 2022	13F
J. Martin Carroll	3/4/5	Director	— class O/S missing	106,864	$239,268	—	10 Aug 2021	3/4/5
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	— class O/S missing	615,407	$234,000	—	31 Mar 2022	13F
SANDERS MORRIS HARRIS LLC	13F	Company	— class O/S missing	512,633	$194,000	—	31 Mar 2022	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	— class O/S missing	443,974	$169,000	—	31 Mar 2022	13F
Traynor Capital Management, Inc.	13F	Company	— class O/S missing	367,991	$139,000	—	31 Mar 2022	13F
GROUP ONE TRADING LLC	13F	Company	— class O/S missing	345,503	$131,000	—	31 Mar 2022	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	— class O/S missing	341,354	$130,000	—	31 Mar 2022	13F
Raymond James Financial Services Advisors, Inc.	13F	Company	— class O/S missing	327,956	$125,000	—	31 Mar 2022	13F
RHUMBLINE ADVISERS	13F	Company	— class O/S missing	312,526	$119,000	—	31 Mar 2022	13F
WELLS FARGO & COMPANY/MN	13F	Company	— class O/S missing	275,216	$105,000	—	31 Mar 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	— class O/S missing	269,267	$102,000	—	31 Mar 2022	13F
JPMORGAN CHASE & CO	13F	Company	— class O/S missing	255,249	$97,000	—	31 Mar 2022	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	— class O/S missing	253,200	$96,000	—	31 Mar 2022	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	— class O/S missing	240,630	$91,000	—	31 Mar 2022	13F
Allspring Global Investments Holdings, LLC	13F	Company	— class O/S missing	225,669	$85,000	—	31 Mar 2022	13F
DEUTSCHE BANK AG\	13F	Company	— class O/S missing	219,612	$83,000	—	31 Mar 2022	13F
GSA CAPITAL PARTNERS LLP	13F	Company	— class O/S missing	208,503	$79,000	—	31 Mar 2022	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	— class O/S missing	202,077	$76,789	—	31 Mar 2022	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	— class O/S missing	193,571	$74,000	—	31 Mar 2022	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	— class O/S missing	168,415	$64,000	—	31 Mar 2022	13F
State of Wyoming	13F	Company	— class O/S missing	165,187	$63,000	—	31 Mar 2022	13F
Invesco Ltd.	13F	Company	— class O/S missing	141,229	$54,000	—	31 Mar 2022	13F
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM	13F	Company	— class O/S missing	136,064	$52,000	—	31 Mar 2022	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	— class O/S missing	132,251	$50,000	—	31 Mar 2022	13F

Institutional Holders of TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD) as of Q2 2022

As of 30 Jun 2022, TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD) was held by 36 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,993,507 shares. The largest 10 holders included Rubric Capital Management LP, VANGUARD GROUP INC, MORGAN STANLEY, BlackRock Inc., Ergoteles LLC, BANK OF AMERICA CORP /DE/, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and GABELLI FUNDS LLC. This page lists 36 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Q2 2022 holders

Holder diff

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.